Business Description
Anixa Biosciences is a California-based medical research company working to develop new treatments and preventive vaccines for some of the most difficult-to-treat cancers, including ovarian, breast, lung, colon, and prostate cancer. The company is advancing a specialized immune cell therapy designed to fight ovarian cancer, alongside a breast cancer vaccine and a broader program aimed at discovering vaccines for other hard-to-treat cancers. Founded in 1982 and headquartered in San Jose, Anixa operates at the cutting edge of cancer science, exploring how certain proteins in the body could serve as targets for next-generation cancer vaccines.
